Company Profile
Panbela Therapeutics Stock Price, News & Analysis
- Ticker:
- PBLA
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.01 USD (+0.91%)
Close
Last updated: July 21, 2026
—
Market cap
Why the stock is moving
Current closing-price context is not available for PBLA.
Company overview
Business overview
Panbela Therapeutics is an oncology company focused on pancreatic cancer and related difficult-to-treat tumors. Its story is built around developing therapies for settings where the unmet need is very high and the market opportunity is tightly tied to data.
Geographic Base and Sector Classification
Panbela is headquartered in the United States and listed on NASDAQ. It sits in small-cap oncology biotechnology.
Business Model Characteristics
The company depends on clinical readouts, strategic focus, and financing to keep a narrow cancer pipeline moving. Investors typically watch proof-of-concept signals and whether the program can create a differentiated path in pancreatic cancer.
Position Within the Biotechnology Landscape
Panbela occupies a classic small oncology niche within biotech. The stock is sensitive to clinical catalysts because the entire story hangs on a limited set of programs.
Future catalysts
Panbela is now a legacy and closeout story, so the catalysts are any final strategic or asset-resolution update rather than a live oncology milestone. The market is focused on what remains after the unwind.
Recent news
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Panbela Therapeutics (PBLA)?
Panbela Therapeutics (PBLA) most recently closed at 0.01 USD, a +0.91% move versus the previous session.
What does Panbela Therapeutics do?
Panbela Therapeutics is an oncology company focused on pancreatic cancer and related difficult-to-treat tumors. Its story is built around developing therapies for settings where the unmet need is very high and the market opportunity is tightly tied to data.
On which exchange is PBLA stock listed?
Panbela Therapeutics (PBLA) is associated with NASDAQ, United States, Biopharma.
What is Panbela?
Panbela is now a legacy and closeout story, so the catalysts are any final strategic or asset-resolution update rather than a live oncology milestone.
Which conditions is Panbela Therapeutics targeting with Panbela?
Panbela Therapeutics is associated with oncology, cancer therapeutics based on its company overview and current catalyst commentary.
How does Panbela Therapeutics describe recent progress with Panbela?
Panbela is now a legacy and closeout story, so the catalysts are any final strategic or asset-resolution update rather than a live oncology milestone.
What is Therapeutics?
Panbela Therapeutics is an oncology company focused on pancreatic cancer and related difficult-to-treat tumors.
What should investors watch for with Therapeutics?
Panbela is now a legacy and closeout story, so the catalysts are any final strategic or asset-resolution update rather than a live oncology milestone. The market is focused on what remains after the unwind.